This report provides a complete analysis of the Global Thyroid Eye Disease Treatment industry in terms of market segmentation By Therapeutic Type (Monoclonal Antibodies, Corticosteroids, Vitamins, and Other Therapies), By Route of Administration (Oral, Parenteral, and Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Channel) for the historical period of 2021-2024, the estimates of 2025 and the forecast period of 2026-2031.
The Global Thyroid Eye Disease Treatment market showcased growth at a CAGR of 9.47% during 2021-2024. The market was valued at USD 4.53 Billion in 2024 which is expected to reach USD 11.81 Billion in 2031. The global market for Thyroid Eye Diseases is seeing substantial expansion and demonstrating an exponential rise. The market is influenced by various factors, including technological improvements and the increasing prevalence of hyperthyroidism and hypothyroidism.
The primary driver of the global thyroid eye disease (TED) treatment market is the increasing prevalence of Graves' disease and thyroid disorders. As TED is commonly associated with Graves' disease, the rising incidence of hyperthyroidism significantly boosts the demand for treatment options. Additionally, growing awareness and early diagnosis have led to higher adoption rates of targeted therapies, supported by advancements in diagnostic technologies such as MRI and CT scans.
Firstly, advancements in therapeutic approaches and increased awareness and knowledge about Thyroid Eye Disease (TED) contribute to the market's expansion. New and improved treatment options are expected to enhance patient outcomes and drive market growth. Secondly, the expansion of medical infrastructure in emerging economies is playing a vital role in driving the Thyroid Eye Disease market. As healthcare systems and facilities improve in these regions, more individuals can access diagnosis and treatment for TED, leading to market growth.
Additionally, the high prevalence of TED, ranging from 25% to 50% among individuals with Graves' disease and the ability of TED to manifest independently of Graves' disease, significantly contribute to market expansion. This widespread occurrence of the condition creates a substantial patient pool and market demand. Furthermore, epidemiological studies indicating an annual incidence rate of 16 cases per 100,000 women and 2.9 cases per 100,000 men in the general population highlight the need for effective treatments, driving the market forward.
Individuals experiencing severe Thyroid Eye Disease (TED), resulting in significant vision impairments and reduced overall quality of life, are more likely to seek medical intervention. This growing demand for various treatment options, including innovative therapies such as monoclonal antibodies and surgical procedures, has the potential to drive market expansion.
Autoimmune disorders can be influenced by environmental factors, including exposure to pollution, chemicals, and radiation. In some developing countries, like India and China, where environmental controls and pollution regulations are inadequate, the risk of developing Thyroid Eye Disease may be elevated.
Moreover, changes in lifestyle and dietary habits, such as increased consumption of processed foods, reduced physical activity, and elevated stress levels, can lead to hormone imbalances. These lifestyle modifications can contribute to a higher incidence of thyroid-related conditions, often linked to Thyroid Eye Disease, further fueling market demand.
The management of Thyroid Eye Disease has undergone a significant transformation, shifting away from conservative methods such as monitoring and surgery in favor of targeted biologic therapies. This shift emphasizes the enhancement of cosmetic outcomes and the improvement of patients' quality of life, positively impacting market dynamics.
Advancements in surgical techniques have also led to improved treatment outcomes while significantly reducing the risk of complications. The proliferation of treatments for the active phase of the disease has had a substantial impact on the quality of life of individuals affected by this condition.
The Global Thyroid Eye Disease Treatment market showcased growth at a CAGR of 9.47% during 2021-2024. The market was valued at USD 4.53 Billion in 2024 which is expected to reach USD 11.81 Billion in 2031. The global market for Thyroid Eye Diseases is seeing substantial expansion and demonstrating an exponential rise. The market is influenced by various factors, including technological improvements and the increasing prevalence of hyperthyroidism and hypothyroidism.
The primary driver of the global thyroid eye disease (TED) treatment market is the increasing prevalence of Graves' disease and thyroid disorders. As TED is commonly associated with Graves' disease, the rising incidence of hyperthyroidism significantly boosts the demand for treatment options. Additionally, growing awareness and early diagnosis have led to higher adoption rates of targeted therapies, supported by advancements in diagnostic technologies such as MRI and CT scans.
Firstly, advancements in therapeutic approaches and increased awareness and knowledge about Thyroid Eye Disease (TED) contribute to the market's expansion. New and improved treatment options are expected to enhance patient outcomes and drive market growth. Secondly, the expansion of medical infrastructure in emerging economies is playing a vital role in driving the Thyroid Eye Disease market. As healthcare systems and facilities improve in these regions, more individuals can access diagnosis and treatment for TED, leading to market growth.
Additionally, the high prevalence of TED, ranging from 25% to 50% among individuals with Graves' disease and the ability of TED to manifest independently of Graves' disease, significantly contribute to market expansion. This widespread occurrence of the condition creates a substantial patient pool and market demand. Furthermore, epidemiological studies indicating an annual incidence rate of 16 cases per 100,000 women and 2.9 cases per 100,000 men in the general population highlight the need for effective treatments, driving the market forward.
Individuals experiencing severe Thyroid Eye Disease (TED), resulting in significant vision impairments and reduced overall quality of life, are more likely to seek medical intervention. This growing demand for various treatment options, including innovative therapies such as monoclonal antibodies and surgical procedures, has the potential to drive market expansion.
Autoimmune disorders can be influenced by environmental factors, including exposure to pollution, chemicals, and radiation. In some developing countries, like India and China, where environmental controls and pollution regulations are inadequate, the risk of developing Thyroid Eye Disease may be elevated.
Moreover, changes in lifestyle and dietary habits, such as increased consumption of processed foods, reduced physical activity, and elevated stress levels, can lead to hormone imbalances. These lifestyle modifications can contribute to a higher incidence of thyroid-related conditions, often linked to Thyroid Eye Disease, further fueling market demand.
The management of Thyroid Eye Disease has undergone a significant transformation, shifting away from conservative methods such as monitoring and surgery in favor of targeted biologic therapies. This shift emphasizes the enhancement of cosmetic outcomes and the improvement of patients' quality of life, positively impacting market dynamics.
Advancements in surgical techniques have also led to improved treatment outcomes while significantly reducing the risk of complications. The proliferation of treatments for the active phase of the disease has had a substantial impact on the quality of life of individuals affected by this condition.
Scope of the Report
- The report analyses the Thyroid Eye Disease Treatment Market by Value (USD Million).
- The report analyses the Thyroid Eye Disease Treatment Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, United Kingdom, France, Germany, Italy, Spain, China, Japan, and India).
- The report presents the analysis of Thyroid Eye Disease Treatment Market for the historical period of 2021-2024, the estimated year 2025 and the forecast period of 2026-2031.
- The report analyses the Thyroid Eye Disease Treatment Market by Therapeutic Type (Monoclonal Antibodies, Corticosteroids, Vitamins, and Other Therapies).
- The report analyses the Thyroid Eye Disease Treatment Market by Route of Administration (Oral, Parenteral, and Topical).
- The report analyses the Thyroid Eye Disease Treatment Market by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Channel).
- The key insights of the report have been presented through the frameworks of SWOT. Also, the attractiveness of the market has been presented by region, by therapeutic type, by route of administration, & by distribution channel.
- Also, the major opportunities, trends, drivers, and challenges of the industry has been analyzed in the report.
- The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analyzed in the report are Amgen, Viridian therapeutics, Novartis AG, Roche holding AG, Sanofi, AbbVie Inc., and Teva Pharmaceutical.
Table of Contents
Table of Contents10. About the Publisher & Disclaimer
1. Market Background
1.1 Scope and Product Outlook
1.2 Executive Summary
1.3 Research Methodology
1.2 Executive Summary
1.3 Research Methodology
2. Analyst Recommendations
2.1 Minimally Invasive Surgical Techniques
2.2 Expansion into Iron Deficient Regions
2.2 Expansion into Iron Deficient Regions
3. Global Thyroid Eye Disease Treatment Market: Historic and Forecast
3.1 Clinical Signs Of Thyroid Eye Disease
3.2 Impact Analysis of Macro Economic Factors on Global Thyroid Eye Disease Treatment Market
3.3 Global Thyroid Eye Disease Treatment Market: Dashboard
3.4 Global Thyroid Eye Disease Treatment Market: Market Value Assessment, 2021-2031 (USD Million)
3.5 Global Thyroid Eye Disease Treatment Market Segmentation: By Therapeutic Type
3.5.1 Global Thyroid Eye Disease Treatment Market, By Therapeutic Type Overview
3.5.2 Global Thyroid Eye Disease Treatment Market Attractiveness Index, By Therapeutic Type
3.5.3 Global Thyroid Eye Disease Treatment Market Size, By Monoclonal Antibodies, By Value, 2018H-2028F (USD Million & CAGR)
3.5.4 Global Thyroid Eye Disease Treatment Market Size, By Corticosteroids, By Value, 2018H-2028F (USD Million & CAGR)
3.5.5 Global Thyroid Eye Disease Treatment Market Size, By Vitamins, By Value, 2018H-2028F (USD Million & CAGR)
3.5.6 Global Thyroid Eye Disease Treatment Market Size, By Other Therapeutics, By Value, 2018H-2028F (USD Million & CAGR)
3.6 Global Thyroid Eye Disease Treatment Market Segmentation: By Route of Administration
3.6.1 Global Thyroid Eye Disease Treatment Market, By Route of Administration Overview
3.6.2 Global Thyroid Eye Disease Treatment Market Attractiveness Index, By Route of Administration
3.6.3 Global Thyroid Eye Disease Treatment Market Size, By Oral, By Value, 2018H-2028F (USD Million & CAGR)
3.6.4 Global Thyroid Eye Disease Treatment Market Size, By Parenteral, By Value, 2018H-2028F (USD Million & CAGR)
3.6.5 Global Thyroid Eye Disease Treatment Market Size, By Topical, By Value, 2018H-2028F (USD Million & CAGR)
3.7 Global Thyroid Eye Disease Treatment Market Segmentation: By Distribution Channel
3.7.1 Global Thyroid Eye Disease Treatment Market, By Distribution Channel Overview
3.7.2 Global Thyroid Eye Disease Treatment Market Attractiveness Index, By Distribution Channel
3.7.3 Global Thyroid Eye Disease Treatment Market Size, By Hospital Pharmacies By Value, 2018H-2028F (USD Million & CAGR)
3.7.4 Global Thyroid Eye Disease Treatment Market Size, By Retail Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)
3.7.5 Global Thyroid Eye Disease Treatment Market Size, By Online Channel, By Value, 2018H-2028F (USD Million & CAGR)
3.2 Impact Analysis of Macro Economic Factors on Global Thyroid Eye Disease Treatment Market
3.3 Global Thyroid Eye Disease Treatment Market: Dashboard
3.4 Global Thyroid Eye Disease Treatment Market: Market Value Assessment, 2021-2031 (USD Million)
3.5 Global Thyroid Eye Disease Treatment Market Segmentation: By Therapeutic Type
3.5.1 Global Thyroid Eye Disease Treatment Market, By Therapeutic Type Overview
3.5.2 Global Thyroid Eye Disease Treatment Market Attractiveness Index, By Therapeutic Type
3.5.3 Global Thyroid Eye Disease Treatment Market Size, By Monoclonal Antibodies, By Value, 2018H-2028F (USD Million & CAGR)
3.5.4 Global Thyroid Eye Disease Treatment Market Size, By Corticosteroids, By Value, 2018H-2028F (USD Million & CAGR)
3.5.5 Global Thyroid Eye Disease Treatment Market Size, By Vitamins, By Value, 2018H-2028F (USD Million & CAGR)
3.5.6 Global Thyroid Eye Disease Treatment Market Size, By Other Therapeutics, By Value, 2018H-2028F (USD Million & CAGR)
3.6 Global Thyroid Eye Disease Treatment Market Segmentation: By Route of Administration
3.6.1 Global Thyroid Eye Disease Treatment Market, By Route of Administration Overview
3.6.2 Global Thyroid Eye Disease Treatment Market Attractiveness Index, By Route of Administration
3.6.3 Global Thyroid Eye Disease Treatment Market Size, By Oral, By Value, 2018H-2028F (USD Million & CAGR)
3.6.4 Global Thyroid Eye Disease Treatment Market Size, By Parenteral, By Value, 2018H-2028F (USD Million & CAGR)
3.6.5 Global Thyroid Eye Disease Treatment Market Size, By Topical, By Value, 2018H-2028F (USD Million & CAGR)
3.7 Global Thyroid Eye Disease Treatment Market Segmentation: By Distribution Channel
3.7.1 Global Thyroid Eye Disease Treatment Market, By Distribution Channel Overview
3.7.2 Global Thyroid Eye Disease Treatment Market Attractiveness Index, By Distribution Channel
3.7.3 Global Thyroid Eye Disease Treatment Market Size, By Hospital Pharmacies By Value, 2018H-2028F (USD Million & CAGR)
3.7.4 Global Thyroid Eye Disease Treatment Market Size, By Retail Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)
3.7.5 Global Thyroid Eye Disease Treatment Market Size, By Online Channel, By Value, 2018H-2028F (USD Million & CAGR)
4. Thyroid Eye Disease Treatment Market, Region Analysis
4.1 Regional Coverage of the Study
4.2 Regional Snapshot
4.2 Regional Snapshot
5. Americas Thyroid Eye Disease Treatment Market: Historic and Forecast
5.1 Americas Thyroid Eye Disease Treatment Market: Snapshot
5.2 Americas Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2021-2031 (USD Million & CAGR)
5.3 Americas Thyroid Eye Disease Treatment Market: Key Factors
5.4 Americas Thyroid Eye Disease Treatment Market: Segment Analysis
5.5 Americas Thyroid Eye Disease Treatment Market Segmentation: By Therapeutic Type
5.5.1 Americas Thyroid Eye Disease Treatment Market, By Therapeutic Type Overview
5.5.2 Americas Thyroid Eye Disease Treatment Market Size, By Monoclonal Antibodies, By Value, 2018H-2028F (USD Million & CAGR)
5.5.3 Americas Thyroid Eye Disease Treatment Market Size, By Corticosteroids, By Value, 2018H-2028F (USD Million & CAGR)
5.5.4 Americas Thyroid Eye Disease Treatment Market Size, By Vitamins, By Value, 2018H-2028F (USD Million & CAGR)
5.5.5 Americas Thyroid Eye Disease Treatment Market Size, By Other Therapeutics, By Value, 2018H-2028F (USD Million & CAGR)
5.6 Americas Thyroid Eye Disease Treatment Market Segmentation: By Route of Administration
5.6.1 Americas Thyroid Eye Disease Treatment Market, By Route of Administration Overview
5.6.2 Americas Thyroid Eye Disease Treatment Market Size, By Oral, By Value, 2018H-2028F (USD Million & CAGR)
5.6.3 Americas Thyroid Eye Disease Treatment Market Size, By Parenteral, By Value, 2018H-2028F (USD Million & CAGR)
5.6.4 Americas Thyroid Eye Disease Treatment Market Size, By Topical, By Value, 2018H-2028F (USD Million & CAGR)
5.7 Americas Thyroid Eye Disease Treatment Market Segmentation: By Distribution Channel
5.7.1 Americas Thyroid Eye Disease Treatment Market, By Distribution Channel Overview
5.7.2 Americas Thyroid Eye Disease Treatment Market Size, By Hospital Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)
5.7.3 Americas Thyroid Eye Disease Treatment Market Size, By Retail Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)
5.7.4 Americas Thyroid Eye Disease Treatment Market Size, By Online Channel, By Value, 2018H-2028F (USD Million & CAGR)
5.8 Americas Thyroid Eye Disease Treatment Market Segmentation: By Country
5.8.1 Americas Thyroid Eye Disease Treatment Market, By Country Overview
5.8.2 United States Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2021-2031 (USD Million & CAGR)
5.8.2.1 United States Thyroid Eye Disease Treatment Market, By Therapeutic Type
5.8.2.2 United States Thyroid Eye Disease Treatment Market, By Route of Administration
5.8.2.3 United States Thyroid Eye Disease Treatment Market, By Distribution Channel
5.8.3 Canada Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2021-2031 (USD Million & CAGR)
5.8.3.1 Canada Thyroid Eye Disease Treatment Market, By Therapeutic Type
5.8.3.2 Canada Thyroid Eye Disease Treatment Market, By Route of Administration
5.8.3.3 Canada Thyroid Eye Disease Treatment Market, By Distribution Channel
5.8.4 Rest of Americas Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2021-2031 (USD Million & CAGR)
5.8.4.1 Rest of Americas Thyroid Eye Disease Treatment Market, By Therapeutic Type
5.8.4.2 Rest of Americas Thyroid Eye Disease Treatment Market, By Route of Administration
5.8.4.3 Rest of Americas Thyroid Eye Disease Treatment Market, By Distribution Channel
5.2 Americas Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2021-2031 (USD Million & CAGR)
5.3 Americas Thyroid Eye Disease Treatment Market: Key Factors
5.4 Americas Thyroid Eye Disease Treatment Market: Segment Analysis
5.5 Americas Thyroid Eye Disease Treatment Market Segmentation: By Therapeutic Type
5.5.1 Americas Thyroid Eye Disease Treatment Market, By Therapeutic Type Overview
5.5.2 Americas Thyroid Eye Disease Treatment Market Size, By Monoclonal Antibodies, By Value, 2018H-2028F (USD Million & CAGR)
5.5.3 Americas Thyroid Eye Disease Treatment Market Size, By Corticosteroids, By Value, 2018H-2028F (USD Million & CAGR)
5.5.4 Americas Thyroid Eye Disease Treatment Market Size, By Vitamins, By Value, 2018H-2028F (USD Million & CAGR)
5.5.5 Americas Thyroid Eye Disease Treatment Market Size, By Other Therapeutics, By Value, 2018H-2028F (USD Million & CAGR)
5.6 Americas Thyroid Eye Disease Treatment Market Segmentation: By Route of Administration
5.6.1 Americas Thyroid Eye Disease Treatment Market, By Route of Administration Overview
5.6.2 Americas Thyroid Eye Disease Treatment Market Size, By Oral, By Value, 2018H-2028F (USD Million & CAGR)
5.6.3 Americas Thyroid Eye Disease Treatment Market Size, By Parenteral, By Value, 2018H-2028F (USD Million & CAGR)
5.6.4 Americas Thyroid Eye Disease Treatment Market Size, By Topical, By Value, 2018H-2028F (USD Million & CAGR)
5.7 Americas Thyroid Eye Disease Treatment Market Segmentation: By Distribution Channel
5.7.1 Americas Thyroid Eye Disease Treatment Market, By Distribution Channel Overview
5.7.2 Americas Thyroid Eye Disease Treatment Market Size, By Hospital Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)
5.7.3 Americas Thyroid Eye Disease Treatment Market Size, By Retail Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)
5.7.4 Americas Thyroid Eye Disease Treatment Market Size, By Online Channel, By Value, 2018H-2028F (USD Million & CAGR)
5.8 Americas Thyroid Eye Disease Treatment Market Segmentation: By Country
5.8.1 Americas Thyroid Eye Disease Treatment Market, By Country Overview
5.8.2 United States Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2021-2031 (USD Million & CAGR)
5.8.2.1 United States Thyroid Eye Disease Treatment Market, By Therapeutic Type
5.8.2.2 United States Thyroid Eye Disease Treatment Market, By Route of Administration
5.8.2.3 United States Thyroid Eye Disease Treatment Market, By Distribution Channel
5.8.3 Canada Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2021-2031 (USD Million & CAGR)
5.8.3.1 Canada Thyroid Eye Disease Treatment Market, By Therapeutic Type
5.8.3.2 Canada Thyroid Eye Disease Treatment Market, By Route of Administration
5.8.3.3 Canada Thyroid Eye Disease Treatment Market, By Distribution Channel
5.8.4 Rest of Americas Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2021-2031 (USD Million & CAGR)
5.8.4.1 Rest of Americas Thyroid Eye Disease Treatment Market, By Therapeutic Type
5.8.4.2 Rest of Americas Thyroid Eye Disease Treatment Market, By Route of Administration
5.8.4.3 Rest of Americas Thyroid Eye Disease Treatment Market, By Distribution Channel
6. Europe Thyroid Eye Disease Treatment Market: Historic and Forecast
6.1 Europe Thyroid Eye Disease Treatment Market: Snapshot
6.2 Europe Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2021-2031 (USD Million & CAGR)
6.3 Europe Thyroid Eye Disease Treatment Market: Key Factors
6.4 Europe Thyroid Eye Disease Treatment Market: Segment Analysis
6.5 Europe Thyroid Eye Disease Treatment Market Segmentation: By Therapeutic Type
6.5.1 Europe Thyroid Eye Disease Treatment Market, By Therapeutic Type Overview
6.5.2 Europe Thyroid Eye Disease Treatment Market Size, By Monoclonal Antibodies, By Value, 2018H-2028F (USD Million & CAGR)
6.5.3 Europe Thyroid Eye Disease Treatment Market Size, By Corticosteroids, By Value, 2018H-2028F (USD Million & CAGR)
6.5.4 Europe Thyroid Eye Disease Treatment Market Size, By Vitamins, By Value, 2018H-2028F (USD Million & CAGR)
6.5.5 Europe Thyroid Eye Disease Treatment Market Size, By Other Therapeutics, By Value, 2018H-2028F (USD Million & CAGR)
6.6 Europe Thyroid Eye Disease Treatment Market Segmentation: By Route of Administration
6.6.1 Europe Thyroid Eye Disease Treatment Market, By Route of Administration Overview
6.6.2 Europe Thyroid Eye Disease Treatment Market Size, By Oral, By Value, 2018H-2028F (USD Million & CAGR)
6.6.3 Europe Thyroid Eye Disease Treatment Market Size, By Parenteral, By Value, 2018H-2028F (USD Million & CAGR)
6.6.4 Europe Thyroid Eye Disease Treatment Market Size, By Topical, By Value, 2018H-2028F (USD Million & CAGR)
6.7 Europe Thyroid Eye Disease Treatment Market Segmentation: By Distribution Channel
6.7.1 Europe Thyroid Eye Disease Treatment Market, By Distribution Channel Overview
6.7.2 Europe Thyroid Eye Disease Treatment Market Size, By Hospital Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)
6.7.3 Europe Thyroid Eye Disease Treatment Market Size, By Retail Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)
6.7.4 Europe Thyroid Eye Disease Treatment Market Size, By Online Channel, By Value, 2018H-2028F (USD Million & CAGR)
6.8 Europe Thyroid Eye Disease Treatment Market Segmentation: By Country
6.8.1 Europe Thyroid Eye Disease Treatment Market, By Country Overview
6.8.2 Germany Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2021-2031 (USD Million & CAGR)
6.8.2.1 Germany Thyroid Eye Disease Treatment Market, By Therapeutic Type
6.8.2.2 Germany Thyroid Eye Disease Treatment Market, By Route of Administration
6.8.2.3 Germany Thyroid Eye Disease Treatment Market, By Distribution Channel
6.8.3 United Kingdom Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2021-2031 (USD Million & CAGR)
6.8.3.1 United Kingdom Thyroid Eye Disease Treatment Market, By Therapeutic Type
6.8.3.2 United Kingdom Thyroid Eye Disease Treatment Market, By Route of Administration
6.8.3.3 United Kingdom Thyroid Eye Disease Treatment Market, By Distribution Channel
6.8.4 France Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2021-2031 (USD Million & CAGR)
6.8.4.1 France Thyroid Eye Disease Treatment Market, By Therapeutic Type
6.8.4.2 France Thyroid Eye Disease Treatment Market, By Route of Administration
6.8.4.3 France Thyroid Eye Disease Treatment Market, By Distribution Channel
6.8.5 Italy Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2021-2031 (USD Million & CAGR)
6.8.5.1 Italy Thyroid Eye Disease Treatment Market, By Therapeutic Type
6.8.5.2 Italy Thyroid Eye Disease Treatment Market, By Route of Administration
6.8.5.3 Italy Thyroid Eye Disease Treatment Market, By Distribution Channel
6.8.6 Spain Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2021-2031 (USD Million & CAGR)
6.8.6.1 Spain Thyroid Eye Disease Treatment Market, By Therapeutic Type
6.8.6.2 Spain Thyroid Eye Disease Treatment Market, By Route of Administration
6.8.6.3 Spain Thyroid Eye Disease Treatment Market, By Distribution Channel
6.8.7 Rest of Europe Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2021-2031 (USD Million & CAGR)
6.8.7.1 Rest of Europe Thyroid Eye Disease Treatment Market, By Therapeutic Type
6.8.7.2 Rest of Europe Thyroid Eye Disease Treatment Market, By Route of Administration
6.8.7.3 Rest of Europe Thyroid Eye Disease Treatment Market, By Distribution Channel
6.2 Europe Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2021-2031 (USD Million & CAGR)
6.3 Europe Thyroid Eye Disease Treatment Market: Key Factors
6.4 Europe Thyroid Eye Disease Treatment Market: Segment Analysis
6.5 Europe Thyroid Eye Disease Treatment Market Segmentation: By Therapeutic Type
6.5.1 Europe Thyroid Eye Disease Treatment Market, By Therapeutic Type Overview
6.5.2 Europe Thyroid Eye Disease Treatment Market Size, By Monoclonal Antibodies, By Value, 2018H-2028F (USD Million & CAGR)
6.5.3 Europe Thyroid Eye Disease Treatment Market Size, By Corticosteroids, By Value, 2018H-2028F (USD Million & CAGR)
6.5.4 Europe Thyroid Eye Disease Treatment Market Size, By Vitamins, By Value, 2018H-2028F (USD Million & CAGR)
6.5.5 Europe Thyroid Eye Disease Treatment Market Size, By Other Therapeutics, By Value, 2018H-2028F (USD Million & CAGR)
6.6 Europe Thyroid Eye Disease Treatment Market Segmentation: By Route of Administration
6.6.1 Europe Thyroid Eye Disease Treatment Market, By Route of Administration Overview
6.6.2 Europe Thyroid Eye Disease Treatment Market Size, By Oral, By Value, 2018H-2028F (USD Million & CAGR)
6.6.3 Europe Thyroid Eye Disease Treatment Market Size, By Parenteral, By Value, 2018H-2028F (USD Million & CAGR)
6.6.4 Europe Thyroid Eye Disease Treatment Market Size, By Topical, By Value, 2018H-2028F (USD Million & CAGR)
6.7 Europe Thyroid Eye Disease Treatment Market Segmentation: By Distribution Channel
6.7.1 Europe Thyroid Eye Disease Treatment Market, By Distribution Channel Overview
6.7.2 Europe Thyroid Eye Disease Treatment Market Size, By Hospital Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)
6.7.3 Europe Thyroid Eye Disease Treatment Market Size, By Retail Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)
6.7.4 Europe Thyroid Eye Disease Treatment Market Size, By Online Channel, By Value, 2018H-2028F (USD Million & CAGR)
6.8 Europe Thyroid Eye Disease Treatment Market Segmentation: By Country
6.8.1 Europe Thyroid Eye Disease Treatment Market, By Country Overview
6.8.2 Germany Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2021-2031 (USD Million & CAGR)
6.8.2.1 Germany Thyroid Eye Disease Treatment Market, By Therapeutic Type
6.8.2.2 Germany Thyroid Eye Disease Treatment Market, By Route of Administration
6.8.2.3 Germany Thyroid Eye Disease Treatment Market, By Distribution Channel
6.8.3 United Kingdom Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2021-2031 (USD Million & CAGR)
6.8.3.1 United Kingdom Thyroid Eye Disease Treatment Market, By Therapeutic Type
6.8.3.2 United Kingdom Thyroid Eye Disease Treatment Market, By Route of Administration
6.8.3.3 United Kingdom Thyroid Eye Disease Treatment Market, By Distribution Channel
6.8.4 France Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2021-2031 (USD Million & CAGR)
6.8.4.1 France Thyroid Eye Disease Treatment Market, By Therapeutic Type
6.8.4.2 France Thyroid Eye Disease Treatment Market, By Route of Administration
6.8.4.3 France Thyroid Eye Disease Treatment Market, By Distribution Channel
6.8.5 Italy Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2021-2031 (USD Million & CAGR)
6.8.5.1 Italy Thyroid Eye Disease Treatment Market, By Therapeutic Type
6.8.5.2 Italy Thyroid Eye Disease Treatment Market, By Route of Administration
6.8.5.3 Italy Thyroid Eye Disease Treatment Market, By Distribution Channel
6.8.6 Spain Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2021-2031 (USD Million & CAGR)
6.8.6.1 Spain Thyroid Eye Disease Treatment Market, By Therapeutic Type
6.8.6.2 Spain Thyroid Eye Disease Treatment Market, By Route of Administration
6.8.6.3 Spain Thyroid Eye Disease Treatment Market, By Distribution Channel
6.8.7 Rest of Europe Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2021-2031 (USD Million & CAGR)
6.8.7.1 Rest of Europe Thyroid Eye Disease Treatment Market, By Therapeutic Type
6.8.7.2 Rest of Europe Thyroid Eye Disease Treatment Market, By Route of Administration
6.8.7.3 Rest of Europe Thyroid Eye Disease Treatment Market, By Distribution Channel
7. Asia Pacific Thyroid Eye Disease Treatment Market: Historic and Forecast
7.1 Asia-Pacific Thyroid Eye Disease Treatment Market: Snapshot
7.2 Asia-Pacific Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2021-2031 (USD Million & CAGR)
7.3 Asia-Pacific Thyroid Eye Disease Treatment Market: Key Factors
7.4 Asia-Pacific Thyroid Eye Disease Treatment Market: Segment Analysis
7.5 Asia-Pacific Thyroid Eye Disease Treatment Market Segmentation: By Therapeutic Type
7.5.1 Asia-Pacific Thyroid Eye Disease Treatment Market, By Therapeutic Type Overview
7.5.2 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Monoclonal Antibodies, By Value, 2018H-2028F (USD Million & CAGR)
7.5.3 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Corticosteroids, By Value, 2018H-2028F (USD Million & CAGR)
7.5.4 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Vitamins, By Value, 2018H-2028F (USD Million & CAGR)
7.5.5 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Other Therapeutics, By Value, 2018H-2028F (USD Million & CAGR)
7.6 Asia-Pacific Thyroid Eye Disease Treatment Market Segmentation: By Route of Administration
7.6.1 Asia-Pacific Thyroid Eye Disease Treatment Market, By Route of Administration Overview
7.6.2 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Oral, By Value, 2018H-2028F (USD Million & CAGR)
7.6.3 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Parenteral, By Value, 2018H-2028F (USD Million & CAGR)
7.6.4 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Topical, By Value, 2018H-2028F (USD Million & CAGR)
7.7 Asia-Pacific Thyroid Eye Disease Treatment Market Segmentation: By Distribution Channel
7.7.1 Asia-Pacific Thyroid Eye Disease Treatment Market, By Distribution Channel Overview
7.7.2 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Hospital Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)
7.7.3 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Retail Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)
7.7.4 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Online Channel, By Value, 2018H-2028F (USD Million & CAGR)
7.8 Asia-Pacific Thyroid Eye Disease Treatment Market Segmentation: By Country
7.8.1 Asia-Pacific Thyroid Eye Disease Treatment Market, By Country Overview
7.8.2 China Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2021-2031 (USD Million & CAGR)
7.8.2.1 China Thyroid Eye Disease Treatment Market, By Therapeutic Type
7.8.2.2 China Thyroid Eye Disease Treatment Market, By Route of Administration
7.8.2.3 China Thyroid Eye Disease Treatment Market, By Distribution Channel
7.8.3 Japan Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2021-2031 (USD Million & CAGR)
7.8.3.1 Japan Thyroid Eye Disease Treatment Market, By Therapeutic Type
7.8.3.2 Japan Thyroid Eye Disease Treatment Market, By Route of Administration
7.8.3.3 Japan Thyroid Eye Disease Treatment Market, By Distribution Channel
7.8.4 India Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2021-2031 (USD Million & CAGR)
7.8.4.1 India Thyroid Eye Disease Treatment Market, By Therapeutic Type
7.8.4.2 India Thyroid Eye Disease Treatment Market, By Route of Administration
7.8.4.3 India Thyroid Eye Disease Treatment Market, By Distribution Channel
7.8.5 Rest of Asia-Pacific Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2021-2031 (USD Million & CAGR)
7.8.5.1 Rest of Asia-Pacific Thyroid Eye Disease Treatment Market, By Therapeutic Type
7.8.5.2 Rest of Asia-Pacific Thyroid Eye Disease Treatment Market, By Route of Administration
7.8.5.3 Rest of Asia-Pacific Thyroid Eye Disease Treatment Market, By Distribution Channel
7.2 Asia-Pacific Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2021-2031 (USD Million & CAGR)
7.3 Asia-Pacific Thyroid Eye Disease Treatment Market: Key Factors
7.4 Asia-Pacific Thyroid Eye Disease Treatment Market: Segment Analysis
7.5 Asia-Pacific Thyroid Eye Disease Treatment Market Segmentation: By Therapeutic Type
7.5.1 Asia-Pacific Thyroid Eye Disease Treatment Market, By Therapeutic Type Overview
7.5.2 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Monoclonal Antibodies, By Value, 2018H-2028F (USD Million & CAGR)
7.5.3 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Corticosteroids, By Value, 2018H-2028F (USD Million & CAGR)
7.5.4 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Vitamins, By Value, 2018H-2028F (USD Million & CAGR)
7.5.5 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Other Therapeutics, By Value, 2018H-2028F (USD Million & CAGR)
7.6 Asia-Pacific Thyroid Eye Disease Treatment Market Segmentation: By Route of Administration
7.6.1 Asia-Pacific Thyroid Eye Disease Treatment Market, By Route of Administration Overview
7.6.2 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Oral, By Value, 2018H-2028F (USD Million & CAGR)
7.6.3 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Parenteral, By Value, 2018H-2028F (USD Million & CAGR)
7.6.4 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Topical, By Value, 2018H-2028F (USD Million & CAGR)
7.7 Asia-Pacific Thyroid Eye Disease Treatment Market Segmentation: By Distribution Channel
7.7.1 Asia-Pacific Thyroid Eye Disease Treatment Market, By Distribution Channel Overview
7.7.2 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Hospital Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)
7.7.3 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Retail Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)
7.7.4 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Online Channel, By Value, 2018H-2028F (USD Million & CAGR)
7.8 Asia-Pacific Thyroid Eye Disease Treatment Market Segmentation: By Country
7.8.1 Asia-Pacific Thyroid Eye Disease Treatment Market, By Country Overview
7.8.2 China Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2021-2031 (USD Million & CAGR)
7.8.2.1 China Thyroid Eye Disease Treatment Market, By Therapeutic Type
7.8.2.2 China Thyroid Eye Disease Treatment Market, By Route of Administration
7.8.2.3 China Thyroid Eye Disease Treatment Market, By Distribution Channel
7.8.3 Japan Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2021-2031 (USD Million & CAGR)
7.8.3.1 Japan Thyroid Eye Disease Treatment Market, By Therapeutic Type
7.8.3.2 Japan Thyroid Eye Disease Treatment Market, By Route of Administration
7.8.3.3 Japan Thyroid Eye Disease Treatment Market, By Distribution Channel
7.8.4 India Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2021-2031 (USD Million & CAGR)
7.8.4.1 India Thyroid Eye Disease Treatment Market, By Therapeutic Type
7.8.4.2 India Thyroid Eye Disease Treatment Market, By Route of Administration
7.8.4.3 India Thyroid Eye Disease Treatment Market, By Distribution Channel
7.8.5 Rest of Asia-Pacific Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2021-2031 (USD Million & CAGR)
7.8.5.1 Rest of Asia-Pacific Thyroid Eye Disease Treatment Market, By Therapeutic Type
7.8.5.2 Rest of Asia-Pacific Thyroid Eye Disease Treatment Market, By Route of Administration
7.8.5.3 Rest of Asia-Pacific Thyroid Eye Disease Treatment Market, By Distribution Channel
8. Middle East & Africa Thyroid Eye Disease Treatment Market: Historic and Forecast
8.1 Middle-East & Africa Thyroid Eye Disease Treatment Market: Snapshot
8.2 Middle-East & Africa Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2021-2031 (USD Million & CAGR)
8.3 Middle-East & Africa Thyroid Eye Disease Treatment Market: Key Factors
8.4 Middle-East & Africa Thyroid Eye Disease Treatment Market: Segment Analysis
8.5 Middle-East & Africa Thyroid Eye Disease Treatment Market Segmentation: By Therapeutic Type
8.5.1 Middle-East & Africa Thyroid Eye Disease Treatment Market, By Therapeutic Type Overview
8.5.2 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Monoclonal Antibodies, By Value, 2018H-2028F (USD Million & CAGR)
8.5.3 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Corticosteroids, By Value, 2018H-2028F (USD Million & CAGR)
8.5.4 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Vitamins, By Value, 2018H-2028F (USD Million & CAGR)
8.5.5 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Other Therapeutics, By Value, 2018H-2028F (USD Million & CAGR)
8.6 Middle-East & Africa Thyroid Eye Disease Treatment Market Segmentation: By Route of Administration
8.6.1 Middle-East & Africa Thyroid Eye Disease Treatment Market, By Route of Administration Overview
8.6.2 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Oral, By Value, 2018H-2028F (USD Million & CAGR)
8.6.3 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Parenteral, By Value, 2018H-2028F (USD Million & CAGR)
8.6.4 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Topical, By Value, 2018H-2028F (USD Million & CAGR)
8.7 Middle-East & Africa Thyroid Eye Disease Treatment Market Segmentation: By Distribution Channel
8.7.1 Middle-East & Africa Thyroid Eye Disease Treatment Market, By Distribution Channel: Overview
8.7.2 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Hospital Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)
8.7.3 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Retail Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)
8.7.4 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Online Channel, By Value, 2018H-2028F (USD Million & CAGR)
8.2 Middle-East & Africa Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2021-2031 (USD Million & CAGR)
8.3 Middle-East & Africa Thyroid Eye Disease Treatment Market: Key Factors
8.4 Middle-East & Africa Thyroid Eye Disease Treatment Market: Segment Analysis
8.5 Middle-East & Africa Thyroid Eye Disease Treatment Market Segmentation: By Therapeutic Type
8.5.1 Middle-East & Africa Thyroid Eye Disease Treatment Market, By Therapeutic Type Overview
8.5.2 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Monoclonal Antibodies, By Value, 2018H-2028F (USD Million & CAGR)
8.5.3 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Corticosteroids, By Value, 2018H-2028F (USD Million & CAGR)
8.5.4 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Vitamins, By Value, 2018H-2028F (USD Million & CAGR)
8.5.5 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Other Therapeutics, By Value, 2018H-2028F (USD Million & CAGR)
8.6 Middle-East & Africa Thyroid Eye Disease Treatment Market Segmentation: By Route of Administration
8.6.1 Middle-East & Africa Thyroid Eye Disease Treatment Market, By Route of Administration Overview
8.6.2 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Oral, By Value, 2018H-2028F (USD Million & CAGR)
8.6.3 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Parenteral, By Value, 2018H-2028F (USD Million & CAGR)
8.6.4 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Topical, By Value, 2018H-2028F (USD Million & CAGR)
8.7 Middle-East & Africa Thyroid Eye Disease Treatment Market Segmentation: By Distribution Channel
8.7.1 Middle-East & Africa Thyroid Eye Disease Treatment Market, By Distribution Channel: Overview
8.7.2 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Hospital Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)
8.7.3 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Retail Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)
8.7.4 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Online Channel, By Value, 2018H-2028F (USD Million & CAGR)
9. Competitive Positioning
9.1 Companies’ Product Positioning
9.2 Market Position Matrix
9.3 Market Share Analysis of Thyroid Eye Disease Treatment Market
9.4 Company Profiles
9.4.1 Amgen
9.4.2 Viridian therapeutics
9.4.3 Novartis AG
9.4.4 Roche holding AG
9.4.5 Sanofi
9.4.6 AbbVie Inc.
9.4.7 Teva Pharmaceutical
9.2 Market Position Matrix
9.3 Market Share Analysis of Thyroid Eye Disease Treatment Market
9.4 Company Profiles
9.4.1 Amgen
9.4.2 Viridian therapeutics
9.4.3 Novartis AG
9.4.4 Roche holding AG
9.4.5 Sanofi
9.4.6 AbbVie Inc.
9.4.7 Teva Pharmaceutical
List of Figures and Tables
Figure 1: Global Thyroid Eye Disease Treatment Market Size, By Value, 2021-2024 (USD Million)
Figure 2: Global Thyroid Eye Disease Treatment Market Size, By Value, 2025-2031 (USD Million)
Figure 3: Global Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, 2024 (%)
Figure 4: Market Attractiveness Analysis of Global Bulk Filtration Market, By Therapeutic Type (2026-2031)
Figure 5: Global Thyroid Eye Disease Treatment Market Size, By Monoclonal Antibodies, By Value, 2021H-2031F (USD Million & CAGR)
Figure 6: Global Thyroid Eye Disease Treatment Market Absolute Opportunity, By Monoclonal Antibodies, 2021-2031 (USD Million)
Figure 7: Global Thyroid Eye Disease Treatment Market Size, By Corticosteroids, By Value, 2021H-2031F (USD Million & CAGR)
Figure 8: Global Thyroid Eye Disease Treatment Market Absolute Opportunity, By Corticosteroids, 2021-2031 (USD Million)
Figure 9: Global Thyroid Eye Disease Treatment Market Size, By Vitamins, By Value, 2021H-2031F (USD Million & CAGR)
Figure 10: Global Thyroid Eye Disease Treatment Market Absolute Opportunity, By Vitamins, 2021-2031 (USD Million)
Figure 11: Global Thyroid Eye Disease Treatment Market Size, By Other Therapeutics, By Value, 2021H-2031F (USD Million & CAGR)
Figure 12: Global Thyroid Eye Disease Treatment Market Absolute Opportunity, By Other Therapeutics, 2021-2031 (USD Million)
Figure 13: Market Attractiveness Analysis of Global Bulk Filtration Market, By Route of Administration (2026-2031)
Figure 14: Global Thyroid Eye Disease Treatment Market Absolute Opportunity, By Oral, 2021-2031 (USD Million)
Figure 15: Global Thyroid Eye Disease Treatment Market Size, By Parenteral, By Value, 2021H-2031F (USD Million & CAGR)
Figure 16: Global Thyroid Eye Disease Treatment Market Size, By Parenteral, By Value, 2021H-2031F (USD Million & CAGR)
Figure 17: Global Thyroid Eye Disease Treatment Market Absolute Opportunity, By Parenteral, 2021-2031 (USD Million)
Figure 18: Global Thyroid Eye Disease Treatment Market Size, By Topical, By Value, 2021H-2031F (USD Million & CAGR)`
Figure 19: Global Thyroid Eye Disease Treatment Market Absolute Opportunity, By Topical, 2021-2031 (USD Million)
Figure 20: Market Attractiveness Analysis of Global Bulk Filtration Market, By Distribution Channel (2026-2031)
Figure 21: Global Thyroid Eye Disease Treatment Market Size, By Hospital Pharmacies, By Value, 2021H-2031F (USD Million & CAGR)
Figure 22: Global Thyroid Eye Disease Treatment Market Absolute Opportunity, By Hospital Pharmacies, 2021-2031 (USD Million)
Figure 23: Global Thyroid Eye Disease Treatment Market Size, By Retail Pharmacies, By Value, 2021H-2031F (USD Million & CAGR)
Figure 24: Global Thyroid Eye Disease Treatment Market Absolute Opportunity, By Retail Pharmacies, 2021-2031 (USD Million)
Figure 25: Global Thyroid Eye Disease Treatment Market Size, By Online Channel, By Value, 2021H-2031F (USD Million & CAGR)
Figure 26: Global Thyroid Eye Disease Treatment Market Absolute Opportunity, By Online Channel, 2021-2031 (USD Million)
Figure 27: Americas Thyroid Eye Disease Treatment Market Size, By Value, 2021H-2031F (USD Million)
Figure 28: Americas Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, 2024 (%)
Figure 29: Americas Thyroid Eye Disease Treatment Market, By Monoclonal Antibodies, By Value, 2021H-2031F (USD Million & CAGR)
Figure 30: Americas Thyroid Eye Disease Treatment Market, By Corticosteroids, By Value, 2021H-2031F (USD Million & CAGR)
Figure 31: Americas Thyroid Eye Disease Treatment Market, By Vitamins, By Value, 2021H-2031F (USD Million & CAGR)
Figure 32: Americas Thyroid Eye Disease Treatment Market , By Other Therapies, By Value, 2021H-2031F (USD Million & CAGR)
Figure 33: Americas Thyroid Eye Disease Treatment Market , By Oral, By Value, 2021H-2031F (USD Million & CAGR)
Figure 34: Americas Thyroid Eye Disease Treatment Market , By Parenteral, By Value, 2021H-2031F (USD Million & CAGR)
Figure 35: Americas Thyroid Eye Disease Treatment Market, By Topical, By Value, 2021H-2031F (USD Million & CAGR)
Figure 36: Americas Thyroid Eye Disease Treatment Market, By Hospital Pharmacies, By Value, 2021H-2031F (USD Million & CAGR)
Figure 37: Americas Thyroid Eye Disease Treatment Market, By Retail Pharmacies, By Value, 2021H-2031F (USD Million & CAGR)
Figure 38: Americas Thyroid Eye Disease Treatment Market, By Online Channel, By Value, 2021H-2031F (USD Million & CAGR)
Figure 39: United States Thyroid Eye Disease Treatment Market, By Value, 2021-2031 (USD Million & CAGR)
Figure 40: United States Thyroid Eye Disease Treatment Market Value, By Route of Administration, 2024 (USD Million)
Figure 41: United States Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2024 (%)
Figure 42: United States Thyroid Eye Disease Treatment Market Share, By Route of Administration, By Value, 2024 (%)
Figure 43: United States Thyroid Eye Disease Treatment Market Share, By Distribution Channel, 2024 (%)
Figure 44: Canada Thyroid Eye Disease Treatment Market, By Value, 2021-2031 (USD Million & CAGR)
Figure 45: Canada Thyroid Eye Disease Treatment Market Value, By Route of Administration, 2024 (USD Million)
Figure 46: Canada Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2024 (%)
Figure 47: Canada Thyroid Eye Disease Treatment Market Share, By Route of Administration, By Value 2024 (%)
Figure 48: Canada Thyroid Eye Disease Treatment Market Share, By Distribution Channel, By Value 2024 (%)
Figure 49: Rest of Americas Thyroid Eye Disease Treatment Market, By Value, 2021-2031 (USD Million & CAGR)
Figure 50: Rest of Americas Thyroid Eye Disease Treatment Market Value, By Route of Administration, 2024 (USD Million)
Figure 51: Rest of Americas Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2024 (%)
Figure 52: Rest of Americas Thyroid Eye Disease Treatment Market Share, By Route of Administration, 2024 (%)
Figure 53: Rest of Americas Thyroid Eye Disease Treatment Market Share, By Distribution Channel, 2024 (%)
Figure 54: Europe Thyroid Eye Disease Treatment Market Size, By Value, 2021H-2031F (USD Million)
Figure 55: Europe Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, 2024 (%)
Figure 56: Europe Thyroid Eye Disease Treatment Market, By Monoclonal Antibodies, By Value, 2021H-2031F (USD Million & CAGR)
Figure 57: Europe Thyroid Eye Disease Treatment Market, By Corticosteroids, By Value, 2021H-2031F (USD Million & CAGR)
Figure 58: Europe Thyroid Eye Disease Treatment Market, By Vitamins, By Value, 2021H-2031F (USD Million & CAGR)
Figure 59: Europe Thyroid Eye Disease Treatment Market, By Other Therapeutics, By Value, 2021H-2031F (USD Million & CAGR)
Figure 60: Europe Thyroid Eye Disease Treatment Market, By Oral, By Value, 2021H-2031F (USD Million & CAGR)
Figure 61: Europe Thyroid Eye Disease Treatment Market, By Parenteral, By Value, 2021H-2031F (USD Million & CAGR)
Figure 62: Europe Thyroid Eye Disease Treatment Market, By Topical, By Value, 2021H-2031F (USD Million & CAGR)
Figure 63: Europe Thyroid Eye Disease Treatment Market, By Hospital Pharmacies, By Value, 2021H-2031F (USD Million & CAGR)
Figure 64: Europe Thyroid Eye Disease Treatment Market, By Retail Pharmacies, By Value, 2021H-2031F (USD Million & CAGR)
Figure 65: Europe Thyroid Eye Disease Treatment Market, By Online Channel, By Value, 2021H-2031F (USD Million & CAGR)
Figure 66: Germany Thyroid Eye Disease Treatment Market, By Value, 2021-2031 (USD Million & CAGR)
Figure 67: Germany Thyroid Eye Disease Treatment Market Value, By Route of Administration, 2024 (USD Million)
Figure 68: Germany Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2024 (%)
Figure 69: Germany Thyroid Eye Disease Treatment Market Share, By Route of Administration, 2024 (%)
Figure 70: Germany Thyroid Eye Disease Treatment Market Share, By Distribution Channel, 2024 (%)
Figure 71: United Kingdom Thyroid Eye Disease Treatment Market, By Value, 2021-2031 (USD Million & CAGR)
Figure 72: United Kingdom Thyroid Eye Disease Treatment Market Value, By Route of Administration, 2024 (USD Million)
Figure 73: United Kingdom Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2024 (%)
Figure 74: United Kingdom Thyroid Eye Disease Treatment Market Share, By Route of Administration, 2024 (%)
Figure 75: United Kingdom Thyroid Eye Disease Treatment Market Share, By Distribution Channel, 2024 (%)
Figure 76: France Thyroid Eye Disease Treatment Market, By Value, 2021-2031 (USD Million & CAGR)
Figure 77: France Thyroid Eye Disease Treatment Market Value, By Route of Administration, 2024 (USD Million)
Figure 78: France Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2024 (%)
Figure 79: France Thyroid Eye Disease Treatment Market Share, By Route of Administration, By Value 2024 (%)
Figure 80: France Thyroid Eye Disease Treatment Market Share, By Distribution Channel, 2024 (%)
Figure 81: Italy Thyroid Eye Disease Treatment Market, By Value, 2021-2031 (USD Million & CAGR)
Figure 82: Italy Thyroid Eye Disease Treatment Market Value, By Route of Administration, 2024 (USD Million)
Figure 83: Italy Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2024 (%)
Figure 84: Italy Thyroid Eye Disease Treatment Market Share, By Route of Administration, 2024 (%)
Figure 85: Italy Thyroid Eye Disease Treatment Market Share, By Distribution Channel, 2024 (%)
Figure 86: Spain Thyroid Eye Disease Treatment Market, By Value, 2021-2031 (USD Million & CAGR)
Figure 87: Spain Thyroid Eye Disease Treatment Market Value, By Route of Administration, 2024 (USD Million)
Figure 88: Spain Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2024 (%)
Figure 89: Spain Thyroid Eye Disease Treatment Market Share, By Route of Administration, 2024 (%)
Figure 90: Spain Thyroid Eye Disease Treatment Market Share, By Distribution Channel, By Value 2024 (%)
Figure 91: Rest of Europe Thyroid Eye Disease Treatment Market, By Value, 2021-2031 (USD Million & CAGR)
Figure 92: Rest of Europe Thyroid Eye Disease Treatment Market Value, By Route of Administration, 2024 (USD Million)
Figure 93: Rest of Europe Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2024 (%)
Figure 94: Rest of Europe Thyroid Eye Disease Treatment Market Share, By Route of Administration, 2024 (%)
Figure 95: Rest of Europe Thyroid Eye Disease Treatment Market Share, By Distribution Channel, 2024 (%)
Figure 96: Asia Pacific Thyroid Eye Disease Treatment Market Size, By Value, 2021H-2031F (USD Million)
Figure 97: Asia Pacific Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, 2024 (%)
Figure 98: Asia Pacific Thyroid Eye Disease Treatment Market, By Monoclonal Antibodies, By Value, 2021H-2031F (USD Million & CAGR)
Figure 99: Asia Pacific Thyroid Eye Disease Treatment Market, By Corticosteroids, By Value, 2021H-2031F (USD Million & CAGR)
Figure 100: Asia Pacific Thyroid Eye Disease Treatment Market, By Vitamins, By Value, 2021H-2031F (USD Million & CAGR)
Figure 101: Asia Pacific Thyroid Eye Disease Treatment Market, By Other Therapeutics, By Value, 2021H-2031F (USD Million & CAGR)
Figure 102: Asia Pacific Thyroid Eye Disease Treatment Market, By Oral, By Value, 2021H-2031F (USD Million & CAGR)
Figure 103: Asia Pacific Thyroid Eye Disease Treatment Market, By Parenteral, By Value, 2021H-2031F (USD Million & CAGR)
Figure 104: Asia Pacific Thyroid Eye Disease Treatment Market, By Topical, By Value, 2021H-2031F (USD Million & CAGR)
Figure 105: Asia Pacific Thyroid Eye Disease Treatment Market, By Hospital Pharmacies, By Value, 2021H-2031F (USD Million & CAGR)
Figure 106: Asia Pacific Thyroid Eye Disease Treatment Market, By Retail Pharmacies, By Value, 2021H-2031F (USD Million & CAGR)
Figure 107: Asia Pacific Thyroid Eye Disease Treatment Market, By Online Channel, By Value, 2021H-2031F (USD Million & CAGR)
Figure 108: China Thyroid Eye Disease Treatment Market, By Value, 2021-2031 (USD Million & CAGR)
Figure 109: China Thyroid Eye Disease Treatment Market Value, By Route of Administration, 2024 (USD Million)
Figure 110: China Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2024 (%)
Figure 111: China Thyroid Eye Disease Treatment Market Share, By Route of Administration, 2024 (%)
Figure 112: China Thyroid Eye Disease Treatment Market Share, By Distribution Channel, 2024 (%)
Figure 113: Japan Thyroid Eye Disease Treatment Market, By Value, 2021-2031 (USD Million & CAGR)
Figure 114: Japan Thyroid Eye Disease Treatment Market Value, By Route of Administration, 2024 (USD Million)
Figure 115: Japan Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2024 (%)
Figure 116: Japan Thyroid Eye Disease Treatment Market Share, By Route of Administration, 2024 (%)
Figure 117: Japan Thyroid Eye Disease Treatment Market Share, By Distribution Channel, 2024 (%)
Figure 118: India Thyroid Eye Disease Treatment Market, By Value, 2021-2031 (USD Million & CAGR)
Figure 119: India Thyroid Eye Disease Treatment Market Value, By Route of Administration, 2024 (USD Million)
Figure 120: India Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2024 (%)
Figure 121: India Thyroid Eye Disease Treatment Market Share, By Route of Administration, By Value 2024 (%)
Figure 122: India Thyroid Eye Disease Treatment Market Share, By Distribution Channel, By Value 2024 (%)
Figure 123: Rest of Asia Pacific Thyroid Eye Disease Treatment Market, By Value, 2021-2031 (USD Million & CAGR)
Figure 124: Rest of Asia Pacific Thyroid Eye Disease Treatment Market Value, By Route of Administration, 2024 (USD Million)
Figure 125: Rest of Asia Pacific Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2024 (%)
Figure 126: Rest of Asia Pacific Thyroid Eye Disease Treatment Market Share, By Route of Administration, 2024 (%)
Figure 127: Rest of Asia Pacific Thyroid Eye Disease Treatment Market Share, By Distribution Channel, 2024 (%)
Figure 128: Middle East and Africa Thyroid Eye Disease Treatment Market Size, By Value, 2021H-2031F (USD Million)
Figure 129: Middle East and Africa Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, 2024 (%)
Figure 130: Middle East and Africa Thyroid Eye Disease Treatment Market, By Monoclonal Antibodies, By Value, 2021H-2031F (USD Million & CAGR)
Figure 131: Middle East and Africa Thyroid Eye Disease Treatment Market, By Corticosteroids, By Value, 2021H-2031F (USD Million & CAGR)
Figure 132: Middle East and Africa Thyroid Eye Disease Treatment Market, By Vitamins, By Value, 2021H-2031F (USD Million & CAGR)
Figure 133: Middle East and Africa Thyroid Eye Disease Treatment Market, By Other Therapies, By Value, 2021H-2031F
(USD Million & CAGR)
Figure 134: Middle East and Africa Thyroid Eye Disease Treatment Market, By Oral, By Value, 2021H-2031F (USD Million & CAGR)
Figure 135: Middle East and Africa Thyroid Eye Disease Treatment Market, By Parenteral, By Value, 2021H-2031F (USD Million & CAGR)
Figure 136: Middle East and Africa Thyroid Eye Disease Treatment Market, By Topical, By Value, 2021H-2031F (USD Million & CAGR)
Figure 137: Middle East and Africa Thyroid Eye Disease Treatment Market, By Hospital Pharmacies, By Value, 2021H-2031F (USD Million & CAGR)
Figure 138: Middle East and Africa Thyroid Eye Disease Treatment Market, By Retail Pharmacies, By Value, 2021H-2031F (USD Million & CAGR)
Figure 139: Middle East and Africa Thyroid Eye Disease Treatment Market, By Online Channel, By Value, 2021H-2031F (USD Million & CAGR)
Figure 140: Market Share of Prominent Companies of Thyroid Eye Disease Treatment Market, 2024 (%)
Figure 141: Amgen, Inc. Revenues, 2021-2023 (USD Million)
Figure 142: Amgen, Inc. Revenues, By Geographic Segments, 2023 (%)
Figure 143: Amgen, Inc. Revenue, By Products, 2023 (%)
Figure 144: Novartis Revenues, 2022-2024 (USD Million)
Figure 145: Novartis Revenue, By Business Segments, 2024 (%)
Figure 146: Novartis Revenue, By Geographical Segments, 2024 (%)
Figure 147: Roche Revenues, 2022-2024 (USD Billion)
Figure 148: Roche Revenue, By Business Segment, 2024 (%)
Figure 149: Roche Revenue, By Geographical Segment, 2024 (%)
Figure 150: Sanofi Revenues, 2021-2023 (USD Billion)
Figure 151: Sanofi Revenues, By Geographic Segments, 2023 (%)
Figure 152: Sanofi Revenue, By Business Segments, 2023 (%)
Figure 153: AbbVie Inc. Revenue, 2021-2023 (USD Million)
Figure 154: AbbVie Inc. Revenue, By Geographical Segments, 2023 (%)
Figure 155: AbbVie Inc. Revenue, By Business Segments, 2023 (%)
Figure 156: Teva Pharmaceuticals Revenues, 2022-2024 (USD Million)
Figure 157: Teva Pharmaceuticals Revenue, By Geographical Segments, 2024 (%)
Table A1: Changes in Eyelid
Table A2: Changes in Facial Muscles
Table A3: Changes in Extraocular Movement
Table A4: Changes in Pupil
Table A5: Other Signs
Table A6: Global Impact of Macro Economic Factors, By Region
Table A7: United States Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2021-2024 (USD Million)
Table A8: United States Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2025-2031 (USD Million)
Table A9: United States Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2021-2024 (USD Million)
Table A10: United States Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2025-2031 (USD Million)
Table A11: United States Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2021-2024 (USD Million)
Table A12: United States Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2025-2031 (USD Million)
Table A13: Canada Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2021-2024 (USD Million)
Table A14: Canada Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2025-2031 (USD Million)
Table A15: Canada Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2021-2024 (USD Million)
Table A16: Canada Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2025-2031 (USD Million)
Table A17: Canada Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2021-2024 (USD Million)
Table A18: Canada Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2025-2031 (USD Million)
Table A19: Rest of Americas Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2021-2024 (USD Million)
Table A20: Rest of Americas Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2025-2031 (USD Million)
Table A21: Rest of Americas Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2021-2024 (USD Million)
Table A22: Rest of Americas Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2025-2031 (USD Million)
Table A23: Rest of Americas Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2021-2024 (USD Million)
Table A24: Rest of Americas Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2025-2031 (USD Million)
Table A25: Germany Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2021-2024 (USD Million)
Table A26: Germany Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2025-2031 (USD Million)
Table A27: Germany Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2021-2024 (USD Million)
Table A28: Germany Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2025-2031 (USD Million)
Table A29: Germany Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2021-2024 (USD Million)
Table A30: Germany Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2025-2031 (USD Million)
Table A31: United Kingdom Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2021-2024 (USD Million)
Table A32: United Kingdom Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2025-2031 (USD Million)
Table A33: United Kingdom Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2021-2024 (USD Million)
Table A34: United Kingdom Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2025-2031 (USD Million)
Table A35: United Kingdom Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2021-2024 (USD Million)
Table A36: United Kingdom Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2025-2031 (USD Million)
Table A37: France Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2021-2024 (USD Million)
Table A38: France Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2025-2031 (USD Million)
Table A39: France Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2021-2024 (USD Million)
Table A40: France Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2025-2031 (USD Million)
Table A41: France Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2021-2024 (USD Million)
Table A42: France Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2025-2031 (USD Million)
Table A43: Italy Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2021-2024 (USD Million)
Table A44: Italy Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2025-2031 (USD Million)
Table A45: Italy Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2021-2024 (USD Million)
Table A46: Italy Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2025-2031 (USD Million)
Table A47: Italy Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2021-2024 (USD Million)
Table A48: Italy Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2025-2031 (USD Million)
Table A49: Spain Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2021-2024 (USD Million)
Table A50: Spain Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2025-2031 (USD Million)
Table A51: Spain Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2021-2024 (USD Million)
Table A52: Spain Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2025-2031 (USD Million)
Table A53: Spain Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2021-2024 (USD Million)
Table A54: Spain Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2025-2031 (USD Million)
Table A55: Rest of Europe Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2021-2024 (USD Million)
Table A56: Rest of Europe Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2025-2031 (USD Million)
Table A57: Rest of Europe Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2021-2024 (USD Million)
Table A58: Rest of Europe Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2025-2031 (USD Million)
Table A59: Rest of Europe Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2021-2024 (USD Million)
Table A60: Rest of Europe Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2025-2031 (USD Million)
Table A61: China Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2021-2024 (USD Million)
Table A62: China Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2025-2031 (USD Million)
Table A63: China Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2021-2024 (USD Million)
Table A64: China Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2025-2031 (USD Million)
Table A65: China Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2021-2024 (USD Million)
Table A66: China Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2025-2031 (USD Million)
Table A67: Japan Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2021-2024 (USD Million)
Table A68: Japan Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2025-2031 (USD Million)
Table A69: Japan Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2021-2024 (USD Million)
Table A70: Japan Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2025-2031 (USD Million)
Table A71: Japan Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2021-2024 (USD Million)
Table A72: Japan Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2025-2031 (USD Million)
Table A73: India Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2021-2024 (USD Million)
Table A74: India Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2025-2031 (USD Million)
Table A75: India Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2021-2024 (USD Million)
Table A76: India Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2025-2031 (USD Million)
Table A77: India Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2021-2024 (USD Million)
Table A78: India Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2025-2031 (USD Million)
Table A79: Rest of Asia Pacific Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2021-2024 (USD Million)
Table A80: Rest of Asia Pacific Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2025-2031 (USD Million)
Table A81: Rest of Asia Pacific Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2021-2024 (USD Million)
Table A82: Rest of Asia Pacific Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2025-2031 (USD Million)
Table A83: Rest of Asia Pacific Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2021-2024 (USD Million)
Table A84: Rest of Asia Pacific Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2025-2031 (USD Million)
Table A85: Amgen, Inc. Key Financials, 2021-2023
Table A86: Novartis Key Company Financials, 2022-2024
Table A87: Roche Key Financials, 2022-2024
Table A88: Sanofi Key Financials, 2021-2023
Table A89: AbbVie Inc. Key Company Financials, 2021-2023
Table A90: Teva Pharmaceuticals Key Financials, 2022-2024
Figure 2: Global Thyroid Eye Disease Treatment Market Size, By Value, 2025-2031 (USD Million)
Figure 3: Global Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, 2024 (%)
Figure 4: Market Attractiveness Analysis of Global Bulk Filtration Market, By Therapeutic Type (2026-2031)
Figure 5: Global Thyroid Eye Disease Treatment Market Size, By Monoclonal Antibodies, By Value, 2021H-2031F (USD Million & CAGR)
Figure 6: Global Thyroid Eye Disease Treatment Market Absolute Opportunity, By Monoclonal Antibodies, 2021-2031 (USD Million)
Figure 7: Global Thyroid Eye Disease Treatment Market Size, By Corticosteroids, By Value, 2021H-2031F (USD Million & CAGR)
Figure 8: Global Thyroid Eye Disease Treatment Market Absolute Opportunity, By Corticosteroids, 2021-2031 (USD Million)
Figure 9: Global Thyroid Eye Disease Treatment Market Size, By Vitamins, By Value, 2021H-2031F (USD Million & CAGR)
Figure 10: Global Thyroid Eye Disease Treatment Market Absolute Opportunity, By Vitamins, 2021-2031 (USD Million)
Figure 11: Global Thyroid Eye Disease Treatment Market Size, By Other Therapeutics, By Value, 2021H-2031F (USD Million & CAGR)
Figure 12: Global Thyroid Eye Disease Treatment Market Absolute Opportunity, By Other Therapeutics, 2021-2031 (USD Million)
Figure 13: Market Attractiveness Analysis of Global Bulk Filtration Market, By Route of Administration (2026-2031)
Figure 14: Global Thyroid Eye Disease Treatment Market Absolute Opportunity, By Oral, 2021-2031 (USD Million)
Figure 15: Global Thyroid Eye Disease Treatment Market Size, By Parenteral, By Value, 2021H-2031F (USD Million & CAGR)
Figure 16: Global Thyroid Eye Disease Treatment Market Size, By Parenteral, By Value, 2021H-2031F (USD Million & CAGR)
Figure 17: Global Thyroid Eye Disease Treatment Market Absolute Opportunity, By Parenteral, 2021-2031 (USD Million)
Figure 18: Global Thyroid Eye Disease Treatment Market Size, By Topical, By Value, 2021H-2031F (USD Million & CAGR)`
Figure 19: Global Thyroid Eye Disease Treatment Market Absolute Opportunity, By Topical, 2021-2031 (USD Million)
Figure 20: Market Attractiveness Analysis of Global Bulk Filtration Market, By Distribution Channel (2026-2031)
Figure 21: Global Thyroid Eye Disease Treatment Market Size, By Hospital Pharmacies, By Value, 2021H-2031F (USD Million & CAGR)
Figure 22: Global Thyroid Eye Disease Treatment Market Absolute Opportunity, By Hospital Pharmacies, 2021-2031 (USD Million)
Figure 23: Global Thyroid Eye Disease Treatment Market Size, By Retail Pharmacies, By Value, 2021H-2031F (USD Million & CAGR)
Figure 24: Global Thyroid Eye Disease Treatment Market Absolute Opportunity, By Retail Pharmacies, 2021-2031 (USD Million)
Figure 25: Global Thyroid Eye Disease Treatment Market Size, By Online Channel, By Value, 2021H-2031F (USD Million & CAGR)
Figure 26: Global Thyroid Eye Disease Treatment Market Absolute Opportunity, By Online Channel, 2021-2031 (USD Million)
Figure 27: Americas Thyroid Eye Disease Treatment Market Size, By Value, 2021H-2031F (USD Million)
Figure 28: Americas Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, 2024 (%)
Figure 29: Americas Thyroid Eye Disease Treatment Market, By Monoclonal Antibodies, By Value, 2021H-2031F (USD Million & CAGR)
Figure 30: Americas Thyroid Eye Disease Treatment Market, By Corticosteroids, By Value, 2021H-2031F (USD Million & CAGR)
Figure 31: Americas Thyroid Eye Disease Treatment Market, By Vitamins, By Value, 2021H-2031F (USD Million & CAGR)
Figure 32: Americas Thyroid Eye Disease Treatment Market , By Other Therapies, By Value, 2021H-2031F (USD Million & CAGR)
Figure 33: Americas Thyroid Eye Disease Treatment Market , By Oral, By Value, 2021H-2031F (USD Million & CAGR)
Figure 34: Americas Thyroid Eye Disease Treatment Market , By Parenteral, By Value, 2021H-2031F (USD Million & CAGR)
Figure 35: Americas Thyroid Eye Disease Treatment Market, By Topical, By Value, 2021H-2031F (USD Million & CAGR)
Figure 36: Americas Thyroid Eye Disease Treatment Market, By Hospital Pharmacies, By Value, 2021H-2031F (USD Million & CAGR)
Figure 37: Americas Thyroid Eye Disease Treatment Market, By Retail Pharmacies, By Value, 2021H-2031F (USD Million & CAGR)
Figure 38: Americas Thyroid Eye Disease Treatment Market, By Online Channel, By Value, 2021H-2031F (USD Million & CAGR)
Figure 39: United States Thyroid Eye Disease Treatment Market, By Value, 2021-2031 (USD Million & CAGR)
Figure 40: United States Thyroid Eye Disease Treatment Market Value, By Route of Administration, 2024 (USD Million)
Figure 41: United States Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2024 (%)
Figure 42: United States Thyroid Eye Disease Treatment Market Share, By Route of Administration, By Value, 2024 (%)
Figure 43: United States Thyroid Eye Disease Treatment Market Share, By Distribution Channel, 2024 (%)
Figure 44: Canada Thyroid Eye Disease Treatment Market, By Value, 2021-2031 (USD Million & CAGR)
Figure 45: Canada Thyroid Eye Disease Treatment Market Value, By Route of Administration, 2024 (USD Million)
Figure 46: Canada Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2024 (%)
Figure 47: Canada Thyroid Eye Disease Treatment Market Share, By Route of Administration, By Value 2024 (%)
Figure 48: Canada Thyroid Eye Disease Treatment Market Share, By Distribution Channel, By Value 2024 (%)
Figure 49: Rest of Americas Thyroid Eye Disease Treatment Market, By Value, 2021-2031 (USD Million & CAGR)
Figure 50: Rest of Americas Thyroid Eye Disease Treatment Market Value, By Route of Administration, 2024 (USD Million)
Figure 51: Rest of Americas Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2024 (%)
Figure 52: Rest of Americas Thyroid Eye Disease Treatment Market Share, By Route of Administration, 2024 (%)
Figure 53: Rest of Americas Thyroid Eye Disease Treatment Market Share, By Distribution Channel, 2024 (%)
Figure 54: Europe Thyroid Eye Disease Treatment Market Size, By Value, 2021H-2031F (USD Million)
Figure 55: Europe Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, 2024 (%)
Figure 56: Europe Thyroid Eye Disease Treatment Market, By Monoclonal Antibodies, By Value, 2021H-2031F (USD Million & CAGR)
Figure 57: Europe Thyroid Eye Disease Treatment Market, By Corticosteroids, By Value, 2021H-2031F (USD Million & CAGR)
Figure 58: Europe Thyroid Eye Disease Treatment Market, By Vitamins, By Value, 2021H-2031F (USD Million & CAGR)
Figure 59: Europe Thyroid Eye Disease Treatment Market, By Other Therapeutics, By Value, 2021H-2031F (USD Million & CAGR)
Figure 60: Europe Thyroid Eye Disease Treatment Market, By Oral, By Value, 2021H-2031F (USD Million & CAGR)
Figure 61: Europe Thyroid Eye Disease Treatment Market, By Parenteral, By Value, 2021H-2031F (USD Million & CAGR)
Figure 62: Europe Thyroid Eye Disease Treatment Market, By Topical, By Value, 2021H-2031F (USD Million & CAGR)
Figure 63: Europe Thyroid Eye Disease Treatment Market, By Hospital Pharmacies, By Value, 2021H-2031F (USD Million & CAGR)
Figure 64: Europe Thyroid Eye Disease Treatment Market, By Retail Pharmacies, By Value, 2021H-2031F (USD Million & CAGR)
Figure 65: Europe Thyroid Eye Disease Treatment Market, By Online Channel, By Value, 2021H-2031F (USD Million & CAGR)
Figure 66: Germany Thyroid Eye Disease Treatment Market, By Value, 2021-2031 (USD Million & CAGR)
Figure 67: Germany Thyroid Eye Disease Treatment Market Value, By Route of Administration, 2024 (USD Million)
Figure 68: Germany Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2024 (%)
Figure 69: Germany Thyroid Eye Disease Treatment Market Share, By Route of Administration, 2024 (%)
Figure 70: Germany Thyroid Eye Disease Treatment Market Share, By Distribution Channel, 2024 (%)
Figure 71: United Kingdom Thyroid Eye Disease Treatment Market, By Value, 2021-2031 (USD Million & CAGR)
Figure 72: United Kingdom Thyroid Eye Disease Treatment Market Value, By Route of Administration, 2024 (USD Million)
Figure 73: United Kingdom Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2024 (%)
Figure 74: United Kingdom Thyroid Eye Disease Treatment Market Share, By Route of Administration, 2024 (%)
Figure 75: United Kingdom Thyroid Eye Disease Treatment Market Share, By Distribution Channel, 2024 (%)
Figure 76: France Thyroid Eye Disease Treatment Market, By Value, 2021-2031 (USD Million & CAGR)
Figure 77: France Thyroid Eye Disease Treatment Market Value, By Route of Administration, 2024 (USD Million)
Figure 78: France Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2024 (%)
Figure 79: France Thyroid Eye Disease Treatment Market Share, By Route of Administration, By Value 2024 (%)
Figure 80: France Thyroid Eye Disease Treatment Market Share, By Distribution Channel, 2024 (%)
Figure 81: Italy Thyroid Eye Disease Treatment Market, By Value, 2021-2031 (USD Million & CAGR)
Figure 82: Italy Thyroid Eye Disease Treatment Market Value, By Route of Administration, 2024 (USD Million)
Figure 83: Italy Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2024 (%)
Figure 84: Italy Thyroid Eye Disease Treatment Market Share, By Route of Administration, 2024 (%)
Figure 85: Italy Thyroid Eye Disease Treatment Market Share, By Distribution Channel, 2024 (%)
Figure 86: Spain Thyroid Eye Disease Treatment Market, By Value, 2021-2031 (USD Million & CAGR)
Figure 87: Spain Thyroid Eye Disease Treatment Market Value, By Route of Administration, 2024 (USD Million)
Figure 88: Spain Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2024 (%)
Figure 89: Spain Thyroid Eye Disease Treatment Market Share, By Route of Administration, 2024 (%)
Figure 90: Spain Thyroid Eye Disease Treatment Market Share, By Distribution Channel, By Value 2024 (%)
Figure 91: Rest of Europe Thyroid Eye Disease Treatment Market, By Value, 2021-2031 (USD Million & CAGR)
Figure 92: Rest of Europe Thyroid Eye Disease Treatment Market Value, By Route of Administration, 2024 (USD Million)
Figure 93: Rest of Europe Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2024 (%)
Figure 94: Rest of Europe Thyroid Eye Disease Treatment Market Share, By Route of Administration, 2024 (%)
Figure 95: Rest of Europe Thyroid Eye Disease Treatment Market Share, By Distribution Channel, 2024 (%)
Figure 96: Asia Pacific Thyroid Eye Disease Treatment Market Size, By Value, 2021H-2031F (USD Million)
Figure 97: Asia Pacific Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, 2024 (%)
Figure 98: Asia Pacific Thyroid Eye Disease Treatment Market, By Monoclonal Antibodies, By Value, 2021H-2031F (USD Million & CAGR)
Figure 99: Asia Pacific Thyroid Eye Disease Treatment Market, By Corticosteroids, By Value, 2021H-2031F (USD Million & CAGR)
Figure 100: Asia Pacific Thyroid Eye Disease Treatment Market, By Vitamins, By Value, 2021H-2031F (USD Million & CAGR)
Figure 101: Asia Pacific Thyroid Eye Disease Treatment Market, By Other Therapeutics, By Value, 2021H-2031F (USD Million & CAGR)
Figure 102: Asia Pacific Thyroid Eye Disease Treatment Market, By Oral, By Value, 2021H-2031F (USD Million & CAGR)
Figure 103: Asia Pacific Thyroid Eye Disease Treatment Market, By Parenteral, By Value, 2021H-2031F (USD Million & CAGR)
Figure 104: Asia Pacific Thyroid Eye Disease Treatment Market, By Topical, By Value, 2021H-2031F (USD Million & CAGR)
Figure 105: Asia Pacific Thyroid Eye Disease Treatment Market, By Hospital Pharmacies, By Value, 2021H-2031F (USD Million & CAGR)
Figure 106: Asia Pacific Thyroid Eye Disease Treatment Market, By Retail Pharmacies, By Value, 2021H-2031F (USD Million & CAGR)
Figure 107: Asia Pacific Thyroid Eye Disease Treatment Market, By Online Channel, By Value, 2021H-2031F (USD Million & CAGR)
Figure 108: China Thyroid Eye Disease Treatment Market, By Value, 2021-2031 (USD Million & CAGR)
Figure 109: China Thyroid Eye Disease Treatment Market Value, By Route of Administration, 2024 (USD Million)
Figure 110: China Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2024 (%)
Figure 111: China Thyroid Eye Disease Treatment Market Share, By Route of Administration, 2024 (%)
Figure 112: China Thyroid Eye Disease Treatment Market Share, By Distribution Channel, 2024 (%)
Figure 113: Japan Thyroid Eye Disease Treatment Market, By Value, 2021-2031 (USD Million & CAGR)
Figure 114: Japan Thyroid Eye Disease Treatment Market Value, By Route of Administration, 2024 (USD Million)
Figure 115: Japan Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2024 (%)
Figure 116: Japan Thyroid Eye Disease Treatment Market Share, By Route of Administration, 2024 (%)
Figure 117: Japan Thyroid Eye Disease Treatment Market Share, By Distribution Channel, 2024 (%)
Figure 118: India Thyroid Eye Disease Treatment Market, By Value, 2021-2031 (USD Million & CAGR)
Figure 119: India Thyroid Eye Disease Treatment Market Value, By Route of Administration, 2024 (USD Million)
Figure 120: India Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2024 (%)
Figure 121: India Thyroid Eye Disease Treatment Market Share, By Route of Administration, By Value 2024 (%)
Figure 122: India Thyroid Eye Disease Treatment Market Share, By Distribution Channel, By Value 2024 (%)
Figure 123: Rest of Asia Pacific Thyroid Eye Disease Treatment Market, By Value, 2021-2031 (USD Million & CAGR)
Figure 124: Rest of Asia Pacific Thyroid Eye Disease Treatment Market Value, By Route of Administration, 2024 (USD Million)
Figure 125: Rest of Asia Pacific Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2024 (%)
Figure 126: Rest of Asia Pacific Thyroid Eye Disease Treatment Market Share, By Route of Administration, 2024 (%)
Figure 127: Rest of Asia Pacific Thyroid Eye Disease Treatment Market Share, By Distribution Channel, 2024 (%)
Figure 128: Middle East and Africa Thyroid Eye Disease Treatment Market Size, By Value, 2021H-2031F (USD Million)
Figure 129: Middle East and Africa Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, 2024 (%)
Figure 130: Middle East and Africa Thyroid Eye Disease Treatment Market, By Monoclonal Antibodies, By Value, 2021H-2031F (USD Million & CAGR)
Figure 131: Middle East and Africa Thyroid Eye Disease Treatment Market, By Corticosteroids, By Value, 2021H-2031F (USD Million & CAGR)
Figure 132: Middle East and Africa Thyroid Eye Disease Treatment Market, By Vitamins, By Value, 2021H-2031F (USD Million & CAGR)
Figure 133: Middle East and Africa Thyroid Eye Disease Treatment Market, By Other Therapies, By Value, 2021H-2031F
(USD Million & CAGR)
Figure 134: Middle East and Africa Thyroid Eye Disease Treatment Market, By Oral, By Value, 2021H-2031F (USD Million & CAGR)
Figure 135: Middle East and Africa Thyroid Eye Disease Treatment Market, By Parenteral, By Value, 2021H-2031F (USD Million & CAGR)
Figure 136: Middle East and Africa Thyroid Eye Disease Treatment Market, By Topical, By Value, 2021H-2031F (USD Million & CAGR)
Figure 137: Middle East and Africa Thyroid Eye Disease Treatment Market, By Hospital Pharmacies, By Value, 2021H-2031F (USD Million & CAGR)
Figure 138: Middle East and Africa Thyroid Eye Disease Treatment Market, By Retail Pharmacies, By Value, 2021H-2031F (USD Million & CAGR)
Figure 139: Middle East and Africa Thyroid Eye Disease Treatment Market, By Online Channel, By Value, 2021H-2031F (USD Million & CAGR)
Figure 140: Market Share of Prominent Companies of Thyroid Eye Disease Treatment Market, 2024 (%)
Figure 141: Amgen, Inc. Revenues, 2021-2023 (USD Million)
Figure 142: Amgen, Inc. Revenues, By Geographic Segments, 2023 (%)
Figure 143: Amgen, Inc. Revenue, By Products, 2023 (%)
Figure 144: Novartis Revenues, 2022-2024 (USD Million)
Figure 145: Novartis Revenue, By Business Segments, 2024 (%)
Figure 146: Novartis Revenue, By Geographical Segments, 2024 (%)
Figure 147: Roche Revenues, 2022-2024 (USD Billion)
Figure 148: Roche Revenue, By Business Segment, 2024 (%)
Figure 149: Roche Revenue, By Geographical Segment, 2024 (%)
Figure 150: Sanofi Revenues, 2021-2023 (USD Billion)
Figure 151: Sanofi Revenues, By Geographic Segments, 2023 (%)
Figure 152: Sanofi Revenue, By Business Segments, 2023 (%)
Figure 153: AbbVie Inc. Revenue, 2021-2023 (USD Million)
Figure 154: AbbVie Inc. Revenue, By Geographical Segments, 2023 (%)
Figure 155: AbbVie Inc. Revenue, By Business Segments, 2023 (%)
Figure 156: Teva Pharmaceuticals Revenues, 2022-2024 (USD Million)
Figure 157: Teva Pharmaceuticals Revenue, By Geographical Segments, 2024 (%)
Table A1: Changes in Eyelid
Table A2: Changes in Facial Muscles
Table A3: Changes in Extraocular Movement
Table A4: Changes in Pupil
Table A5: Other Signs
Table A6: Global Impact of Macro Economic Factors, By Region
Table A7: United States Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2021-2024 (USD Million)
Table A8: United States Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2025-2031 (USD Million)
Table A9: United States Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2021-2024 (USD Million)
Table A10: United States Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2025-2031 (USD Million)
Table A11: United States Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2021-2024 (USD Million)
Table A12: United States Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2025-2031 (USD Million)
Table A13: Canada Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2021-2024 (USD Million)
Table A14: Canada Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2025-2031 (USD Million)
Table A15: Canada Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2021-2024 (USD Million)
Table A16: Canada Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2025-2031 (USD Million)
Table A17: Canada Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2021-2024 (USD Million)
Table A18: Canada Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2025-2031 (USD Million)
Table A19: Rest of Americas Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2021-2024 (USD Million)
Table A20: Rest of Americas Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2025-2031 (USD Million)
Table A21: Rest of Americas Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2021-2024 (USD Million)
Table A22: Rest of Americas Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2025-2031 (USD Million)
Table A23: Rest of Americas Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2021-2024 (USD Million)
Table A24: Rest of Americas Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2025-2031 (USD Million)
Table A25: Germany Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2021-2024 (USD Million)
Table A26: Germany Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2025-2031 (USD Million)
Table A27: Germany Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2021-2024 (USD Million)
Table A28: Germany Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2025-2031 (USD Million)
Table A29: Germany Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2021-2024 (USD Million)
Table A30: Germany Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2025-2031 (USD Million)
Table A31: United Kingdom Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2021-2024 (USD Million)
Table A32: United Kingdom Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2025-2031 (USD Million)
Table A33: United Kingdom Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2021-2024 (USD Million)
Table A34: United Kingdom Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2025-2031 (USD Million)
Table A35: United Kingdom Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2021-2024 (USD Million)
Table A36: United Kingdom Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2025-2031 (USD Million)
Table A37: France Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2021-2024 (USD Million)
Table A38: France Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2025-2031 (USD Million)
Table A39: France Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2021-2024 (USD Million)
Table A40: France Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2025-2031 (USD Million)
Table A41: France Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2021-2024 (USD Million)
Table A42: France Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2025-2031 (USD Million)
Table A43: Italy Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2021-2024 (USD Million)
Table A44: Italy Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2025-2031 (USD Million)
Table A45: Italy Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2021-2024 (USD Million)
Table A46: Italy Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2025-2031 (USD Million)
Table A47: Italy Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2021-2024 (USD Million)
Table A48: Italy Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2025-2031 (USD Million)
Table A49: Spain Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2021-2024 (USD Million)
Table A50: Spain Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2025-2031 (USD Million)
Table A51: Spain Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2021-2024 (USD Million)
Table A52: Spain Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2025-2031 (USD Million)
Table A53: Spain Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2021-2024 (USD Million)
Table A54: Spain Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2025-2031 (USD Million)
Table A55: Rest of Europe Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2021-2024 (USD Million)
Table A56: Rest of Europe Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2025-2031 (USD Million)
Table A57: Rest of Europe Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2021-2024 (USD Million)
Table A58: Rest of Europe Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2025-2031 (USD Million)
Table A59: Rest of Europe Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2021-2024 (USD Million)
Table A60: Rest of Europe Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2025-2031 (USD Million)
Table A61: China Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2021-2024 (USD Million)
Table A62: China Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2025-2031 (USD Million)
Table A63: China Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2021-2024 (USD Million)
Table A64: China Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2025-2031 (USD Million)
Table A65: China Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2021-2024 (USD Million)
Table A66: China Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2025-2031 (USD Million)
Table A67: Japan Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2021-2024 (USD Million)
Table A68: Japan Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2025-2031 (USD Million)
Table A69: Japan Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2021-2024 (USD Million)
Table A70: Japan Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2025-2031 (USD Million)
Table A71: Japan Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2021-2024 (USD Million)
Table A72: Japan Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2025-2031 (USD Million)
Table A73: India Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2021-2024 (USD Million)
Table A74: India Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2025-2031 (USD Million)
Table A75: India Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2021-2024 (USD Million)
Table A76: India Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2025-2031 (USD Million)
Table A77: India Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2021-2024 (USD Million)
Table A78: India Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2025-2031 (USD Million)
Table A79: Rest of Asia Pacific Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2021-2024 (USD Million)
Table A80: Rest of Asia Pacific Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2025-2031 (USD Million)
Table A81: Rest of Asia Pacific Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2021-2024 (USD Million)
Table A82: Rest of Asia Pacific Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2025-2031 (USD Million)
Table A83: Rest of Asia Pacific Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2021-2024 (USD Million)
Table A84: Rest of Asia Pacific Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2025-2031 (USD Million)
Table A85: Amgen, Inc. Key Financials, 2021-2023
Table A86: Novartis Key Company Financials, 2022-2024
Table A87: Roche Key Financials, 2022-2024
Table A88: Sanofi Key Financials, 2021-2023
Table A89: AbbVie Inc. Key Company Financials, 2021-2023
Table A90: Teva Pharmaceuticals Key Financials, 2022-2024
